Estadístiques de Rucaparib in recurrent ovarian cancer. Real-world experience from the rucaparib early access programme in Spain - A GEICO study
Visites totals
| views | |
|---|---|
| Rucaparib in recurrent ovarian cancer. Real-world experience from the rucaparib early access programme in Spain - A GEICO study | 41 |
Visites totals per mes
| views | |
|---|---|
| May 2025 | 2 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 1 |
| November 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| yubero-bmc-ruca.pdf | 137 |
| yubero-bmc-ruca.pdf(legacy) | 13 |
Vistes principals per país
| views | |
|---|---|
| United States | 27 |
| France | 4 |
| Canada | 2 |
| Greece | 2 |
| Ireland | 2 |
| Spain | 1 |
| South Korea | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Ann Arbor | 7 |
| Boardman | 5 |
| Mountain View | 5 |
| Rezé | 4 |
| Menlo Park | 3 |
| Athens | 2 |
| Montréal | 2 |
| Ashburn | 1 |
| Barcelona | 1 |
| Cambridge | 1 |
| Dublin | 1 |
| Sacramento | 1 |
| Shah Alam | 1 |